Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial

Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Meth...

Full description

Bibliographic Details
Main Authors: Eva M. Zwaan, Elena S. Cheung, Alexander J. J. IJsselmuiden, Carlo A. J. Holtzer, Ton A. R. Schreuders, Marcel J. M Kofflard, J. Henk Coert
Format: Article
Language:English
Published: Hindawi-Wiley 2022-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2022/6858962
_version_ 1798036306092097536
author Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
author_facet Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
author_sort Eva M. Zwaan
collection DOAJ
description Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted for PCI. Patients treated with transfemoral PCI (TF-PCI) acted as a control group. A composite score of physical examinations and questionnaires was used for determining UED. Clinical outcomes were monitored during six months of follow-up, with its primary endpoint at two weeks. Results. A total of 440 TR-PCI and 62 control patients were included. Complete case analysis (n = 330) at 2 weeks of follow-up showed that UED in the TR-PCI group was significantly higher than that in the TF-PCI group: 32.7% versus 13.9%, respectively (p=0.04). The three impaired variables most contributing to UED were impaired elbow extension, wrist flexion, and extension. Multivariate logistic regression showed that smokers were almost three times more likely to develop UED. Conclusions. This study demonstrates that UED seems to occur two times more in TR-PCI than in TF-PCI at 2 weeks of follow-up. However, no significant long-term difference or difference between the intervention arm and the contralateral arm was found at all timepoints.
first_indexed 2024-04-11T21:11:05Z
format Article
id doaj.art-4c999dc010534e4b988a24e01674ea45
institution Directory Open Access Journal
issn 1540-8183
language English
last_indexed 2024-04-11T21:11:05Z
publishDate 2022-01-01
publisher Hindawi-Wiley
record_format Article
series Journal of Interventional Cardiology
spelling doaj.art-4c999dc010534e4b988a24e01674ea452022-12-22T04:03:01ZengHindawi-WileyJournal of Interventional Cardiology1540-81832022-01-01202210.1155/2022/6858962Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS TrialEva M. Zwaan0Elena S. Cheung1Alexander J. J. IJsselmuiden2Carlo A. J. Holtzer3Ton A. R. Schreuders4Marcel J. M Kofflard5J. Henk Coert6Department of Plastic Surgery and Reconstructive SurgeryDepartment of Plastic Surgery and Reconstructive SurgeryDepartment of CardiologyDepartment of Plastic Surgery and Hand SurgeryDepartment of Plastic Surgery and Reconstructive SurgeryDepartment of CardiologyDepartment of Plastic Surgery and Reconstructive SurgeryObjectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted for PCI. Patients treated with transfemoral PCI (TF-PCI) acted as a control group. A composite score of physical examinations and questionnaires was used for determining UED. Clinical outcomes were monitored during six months of follow-up, with its primary endpoint at two weeks. Results. A total of 440 TR-PCI and 62 control patients were included. Complete case analysis (n = 330) at 2 weeks of follow-up showed that UED in the TR-PCI group was significantly higher than that in the TF-PCI group: 32.7% versus 13.9%, respectively (p=0.04). The three impaired variables most contributing to UED were impaired elbow extension, wrist flexion, and extension. Multivariate logistic regression showed that smokers were almost three times more likely to develop UED. Conclusions. This study demonstrates that UED seems to occur two times more in TR-PCI than in TF-PCI at 2 weeks of follow-up. However, no significant long-term difference or difference between the intervention arm and the contralateral arm was found at all timepoints.http://dx.doi.org/10.1155/2022/6858962
spellingShingle Eva M. Zwaan
Elena S. Cheung
Alexander J. J. IJsselmuiden
Carlo A. J. Holtzer
Ton A. R. Schreuders
Marcel J. M Kofflard
J. Henk Coert
Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
Journal of Interventional Cardiology
title Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_full Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_fullStr Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_full_unstemmed Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_short Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial
title_sort upper extremity function following transradial percutaneous coronary intervention results of the arcus trial
url http://dx.doi.org/10.1155/2022/6858962
work_keys_str_mv AT evamzwaan upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT elenascheung upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT alexanderjjijsselmuiden upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT carloajholtzer upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT tonarschreuders upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT marceljmkofflard upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial
AT jhenkcoert upperextremityfunctionfollowingtransradialpercutaneouscoronaryinterventionresultsofthearcustrial